Fibrolamellar Carcinoma Latest Advances
Find the Latest Research About Fibrolamellar Carcinoma
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 456 publications
CRE26-070: Refractory Hyperammonemic Encephalopathy as a Paraneoplastic Presentation of Fibrolamellar Hepatocellular Carcinoma: A Case Report.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 30, 2026
Correction: DNAJB1-PRKACA fusion protein-regulated LINC00473 promotes tumor growth and alters mitochondrial fitness in fibrolamellar carcinoma.
Journal: PLoS genetics
Published: February 26, 2026
A Case-Based Review of Advanced Surgical Techniques in the Treatment of Incidentally Diagnosed Fibrolamellar Hepatocellular Carcinoma.
Journal: Cureus
Published: January 15, 2026
Neoantigen-based vaccination unlocks precision immunotherapy in fibrolamellar carcinoma.
Journal: Journal of hepatology
Published: December 29, 2025
Serum Procalcitonin: A Novel Tumor Biomarker for Diagnosis and Follow-Up in Fibrolamellar Hepatocellular Carcinoma.
Journal: medRxiv : the preprint server for health sciences
Published: December 03, 2025
Fibrolamellar Hepatocellular Carcinoma: A Case Report of 25-Year Postoperative Survival.
Journal: Cureus
Published: November 17, 2025
Managing Advanced Fibrolamellar Carcinoma at Stage IV: A Case Report.
Journal: GE Portuguese journal of gastroenterology
Published: November 05, 2025
Serum procalcitonin: A novel tumor biomarker for diagnosis and disease monitoring in fibrolamellar hepatocellular carcinoma.
Journal: Journal of hepatology
Published: October 15, 2025
Procalcitonin as a potential tumor marker for fibrolamellar hepatocellular carcinoma: Insights from three patients and a literature review.
Journal: Frontiers in medicine
Published: October 04, 2025
Clinical guideline for the diagnosis and treatment of fibrolamellar carcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: September 02, 2025
Clinicopathological features and treatment outcomes of patients with fibrolamellar hepatocellular carcinoma: a retrospective multicenter study.
Journal: Annals of Saudi medicine
Published: August 03, 2025
Last Updated: 04/28/2026